# Bolt Biotherapeutics, Inc.: Form 8-K, filed Sep 4, 2024

- Company: [Bolt Biotherapeutics, Inc.](/companies/bolt.md) (CIK 1641281)
- Form: 8-K
- Filed: 2024-09-04
- Accepted by EDGAR: Sep 4, 2024, 17:38 ET
- Period: 2024-08-28
- Accession: 0001193125-24-213225
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1641281/000119312524213225/d886159d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1641281/000119312524213225/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1641281/000119312524213225/d886159d8k.htm

Filed Sep 4, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-213225. Last ingested by Listed: Nov 13, 2026, 15:45 ET. No prices; not investment advice.
